Can-Fite BioPharma Ltd. (CANF) Balance Sheet
CANF balance sheet, 2025
December 31, 2025 · U.S. dollars$9.5M assets = $3.9M liabilities + $5.6M equity
Both columns are drawn to the same scale: what CANF owns equals what it owes plus shareholders’ equity. Hover a block for its value.
CANF financial health
Descriptive bands, not a rating. Fiscal 2025.
CANF balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $10.2M2016 | $9.5M2025 | −0.7%/yr | |
| Total liabilities | $6.3M2016 | $3.9M2025 | −5.1%/yr | |
| Shareholders’ equity | $3.9M2016 | $5.6M2025 | +4.2%/yr | |
| Cash & short-term investments | $8.1M2016 | $8.5M2025 | +0.6%/yr | |
| Total debt | $564,7522016 | $70,9982025 | −20.6%/yr | |
| Net cash (debt) | $7.5M2016 | $8.5M2025 | +$921,782 | |
| Working capital | $7.6M2016 | $6.7M2025 | −$892,102 | |
| Current ratio | 4.042016 | 3.462025 | −0.58 | |
| Debt / equity | 0.152016 | 0.012025 | −0.13 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CANF assets
CANF liabilities and equity
CANF debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
CANF balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $8.5M | $7.9M | $8.9M | $8.0M | $19.1M | $8.3M | $2.8M | $3.9M | $3.5M | $8.1M |
| Cash & equivalents | $5.5M | $4.8M | $4.3M | $3.0M | $4.4M | $8.3M | $2.7M | $3.6M | $3.5M | $8.1M |
| Short-term investments | $3.0M | $3.1M | $4.6M | $5.0M | $14.7M | $75,000 | $64,000 | $273,000 | — | — |
| Receivables | $73,998 | $76,999 | $78,000 | $47,000 | $48,000 | $18,000 | $637,000 | $4.0M | $3.4M | $21,837 |
| Inventory | $0 | $0 | $0 | −$39,000 | −$48,000 | −$92,999 | −$715,000 | −$4.0M | −$3.3M | $0 |
| Other current assets | $825,988 | $1.0M | $908,000 | $1.2M | $929,000 | $1.1M | $4.5M | $4.0M | $3.3M | $2.0M |
| Total current assets | $9.4M | $9.0M | $9.9M | $9.2M | $20.1M | $9.4M | $7.1M | $7.9M | $6.9M | $10.1M |
| Property, plant & equipment (net) | $73,998 | $138,000 | $81,000 | $126,000 | $185,000 | $123,000 | $118,000 | $47,000 | $46,035 | $53,293 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $914,662 | $0 |
| Other non-current assets | $1 | $0 | $0 | $0 | $0 | $0 | $912,000 | $2,000 | $5,179 | $9,620 |
| Total assets | $9.5M | $9.1M | $10.0M | $9.3M | $20.3M | $9.5M | $8.2M | $8.0M | $7.8M | $10.2M |
| Liabilities | ||||||||||
| Accounts payable | $1.2M | $618,000 | $427,000 | $896,000 | $954,000 | $561,000 | $2.2M | $1.1M | $1.4M | $1.2M |
| Short-term debt | $56,000 | $53,000 | $27,000 | $48,000 | $53,000 | $43,000 | $36,000 | — | $998,101 | $564,752 |
| Deferred revenue | $404,993 | $405,000 | $622,000 | $783,000 | $818,000 | $334,000 | $469,000 | $926,000 | $373,748 | $321,582 |
| Total current liabilities | $2.7M | $2.1M | $2.0M | $2.5M | $2.7M | $1.3M | $3.3M | $3.1M | $1.8M | $2.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $39,000 | $0 | $0 | $0 |
| Lease obligations | $71,000 | $104,000 | $40,000 | $62,000 | $124,000 | $67,000 | $75,000 | — | — | — |
| Other long-term liabilities | $1.2M | $1.6M | $1.7M | $2.3M | $3.1M | $2.2M | $2.4M | $1.8M | $3.0M | $3.8M |
| Total liabilities | $3.9M | $3.7M | $3.7M | $4.8M | $5.9M | $3.4M | $5.7M | $4.9M | $4.8M | $6.3M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | — | — | — | — | $60.7M | $33.0M | $8.2M | $2.6M | $2.4M | $1.8M |
| Retained earnings (deficit) | −$176.2M | −$166.4M | −$158.5M | −$150.8M | −$140.7M | −$125.5M | −$110.3M | −$100.6M | −$105.7M | −$91.0M |
| Treasury stock | — | — | — | — | — | — | — | — | — | −$1.0M |
| Accumulated other comprehensive income | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $6.9M | $6.3M | $5.1M |
| Total shareholders' equity | $5.6M | $5.4M | $6.2M | $4.5M | $14.4M | $6.1M | $2.4M | $3.0M | $3.1M | $3.9M |
| Key figures | ||||||||||
| Total debt | $70,998 | $104,000 | $40,000 | $62,000 | $124,000 | $67,000 | $75,000 | — | $998,101 | $564,752 |
| Net cash (debt) | $8.5M | $7.8M | $8.9M | $7.9M | $19.0M | $8.3M | $2.7M | — | $2.5M | $7.5M |
| Working capital | $6.7M | $6.9M | $7.9M | $6.7M | $17.3M | $8.1M | $3.9M | $4.8M | $5.1M | $7.6M |
| Tangible book value | $5.6M | $5.4M | $6.2M | $4.5M | $14.4M | $6.1M | $2.4M | $3.0M | $3.1M | $3.9M |
| Book value per share | — | — | — | — | — | — | — | — | — | $0.28 |
| Shares outstanding | — | — | — | — | — | — | — | — | — | 13.8M |
| Current ratio | 3.46 | 4.38 | 4.90 | 3.66 | 7.35 | 7.41 | 2.18 | 2.53 | 3.82 | 4.04 |
| Quick ratio | 3.15 | 3.88 | 4.46 | 3.21 | 7.03 | 6.59 | 1.04 | 2.53 | 3.82 | 3.25 |
| Debt / equity | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | — | 0.33 | 0.15 |
| Equity / assets | 58.8% | 59.6% | 62.5% | 48.2% | 71.0% | 63.8% | 29.9% | 37.9% | 39.0% | 38.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $7.0M | $7.0M | $8.5M | $8.5M | $6.5M | $6.5M | $7.9M | $7.9M | $4.7M | $4.7M | $8.9M | $7.9M |
| Cash & equivalents | $3.0M | $3.0M | $5.5M | $5.5M | $6.5M | $6.5M | $4.8M | $4.8M | $4.7M | $4.7M | $4.3M | $3.4M |
| Short-term investments | $4.1M | $4.1M | $3.0M | $3.0M | $2,000 | $2,000 | $3.1M | $3.1M | $9,000 | $9,000 | $4.6M | $4.6M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $76,999 | $0 | $0 | $0 | $0 | $78,000 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $960,000 | $960,000 | $900,000 | $900,000 | $1.2M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $908,000 | $1.1M |
| Total current assets | $8.0M | $8.0M | $9.4M | $9.4M | $7.6M | $7.6M | $9.0M | $9.0M | $5.8M | $5.8M | $9.9M | $9.1M |
| Property, plant & equipment (net) | $52,000 | $52,000 | $74,000 | $74,000 | $96,000 | $96,000 | $138,000 | $138,000 | $94,000 | $94,000 | $81,000 | $105,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $8.1M | $8.1M | $9.5M | $9.5M | $7.7M | $7.7M | $9.1M | $9.1M | $5.9M | $5.9M | $10.0M | $9.2M |
| Liabilities | ||||||||||||
| Accounts payable | $681,000 | $681,000 | $1.2M | $1.2M | $1.2M | $1.2M | $618,000 | $618,000 | $885,000 | $885,000 | $427,000 | $647,000 |
| Short-term debt | $48,000 | $48,000 | $56,000 | $56,000 | $57,000 | $57,000 | $53,000 | $53,000 | $36,000 | $36,000 | $27,000 | $34,000 |
| Deferred revenue | — | — | $405,000 | — | $405,000 | $405,000 | $405,000 | — | $636,000 | — | $622,000 | $783,000 |
| Total current liabilities | $2.2M | $2.2M | $2.7M | $2.7M | $2.1M | $2.1M | $2.1M | $2.1M | $2.0M | $2.0M | $2.0M | $2.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $71,000 | — | $90,000 | — | $104,000 | — | $57,000 | — | $40,000 | $51,000 |
| Other long-term liabilities | $975,000 | $975,000 | $1.2M | $1.2M | $1.4M | $1.4M | $1.6M | $1.6M | $1.5M | $1.5M | $1.7M | $1.7M |
| Total liabilities | $3.2M | $3.2M | $3.9M | $3.9M | $3.5M | $3.5M | $3.7M | $3.7M | $3.4M | $3.4M | $3.7M | $3.9M |
| Shareholders' equity | ||||||||||||
| Retained earnings (deficit) | −$180.8M | −$180.8M | −$176.2M | −$176.2M | −$171.2M | −$171.2M | −$166.4M | −$166.4M | −$162.4M | −$162.4M | −$158.5M | −$156.8M |
| Accumulated other comprehensive income | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M |
| Total shareholders' equity | $4.9M | $4.9M | $5.6M | $5.6M | $4.2M | $4.2M | $5.4M | $5.4M | $2.5M | $2.5M | $6.2M | $5.2M |
| Key figures | ||||||||||||
| Total debt | $49,000 | $49,000 | $71,000 | $71,000 | $90,000 | $90,000 | $104,000 | $104,000 | $57,000 | $57,000 | $40,000 | $51,000 |
| Net cash (debt) | $7.0M | $7.0M | $8.5M | $8.5M | $6.4M | $6.4M | $7.8M | $7.8M | $4.7M | $4.7M | $8.9M | $7.9M |
| Working capital | $5.8M | $5.8M | $6.7M | $6.7M | $5.5M | $5.5M | $6.9M | $6.9M | $3.8M | $3.8M | $7.9M | $6.9M |
| Tangible book value | $4.9M | $4.9M | $5.6M | $5.6M | $4.2M | $4.2M | $5.4M | $5.4M | $2.5M | $2.5M | $6.2M | $5.2M |
| Book value per share | $1.31 | $1.31 | — | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 3.7M | 3.7M | — | — | — | — | — | — | — | — | — | — |
| Current ratio | 3.60 | 3.60 | 3.46 | 3.46 | 3.60 | 3.60 | 4.38 | 4.38 | 2.93 | 2.93 | 4.90 | 4.10 |
| Quick ratio | 3.17 | 3.17 | 3.13 | 3.13 | 3.05 | 3.08 | 3.84 | 3.84 | 2.38 | 2.38 | 4.46 | 3.59 |
| Debt / equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Equity / assets | 60.3% | 60.3% | 58.8% | 58.8% | 54.2% | 54.2% | 59.6% | 59.6% | 41.9% | 41.9% | 62.5% | 57.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2026); data from EODHD.
CANF financial position
At the end of fiscal 2025 (December 31, 2025), Can-Fite BioPharma had total assets of $9.5 million (up 4.3% from a year earlier), total liabilities of $3.9 million and shareholders' equity of $5.6 million. It held $8.5 million in cash and short-term investments against $0.1 million of debt, a net cash position of $8.5 million. Its current ratio was 3.46. In the latest quarter (ended June 30, 2026) total assets were $8.1 million and equity $4.9 million.
Related: CANF income statement, CANF cash flow statement, CANF key metrics. See the CANF stock overview for the latest quote and news.
CANF balance sheet FAQ
What are Can-Fite BioPharma's total assets?
Can-Fite BioPharma reported total assets of $9.5 million at the end of fiscal 2025 (December 31, 2025), compared with $9.1 million a year earlier.
How much debt does Can-Fite BioPharma have?
Can-Fite BioPharma had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.01.
How much cash does Can-Fite BioPharma have?
Can-Fite BioPharma held $8.5 million in cash and short-term investments at the end of fiscal 2025; with $0.1 million of debt that is net cash of $8.5 million.
What is Can-Fite BioPharma's book value?
Can-Fite BioPharma's shareholders' equity (book value) was $5.6 million at the end of fiscal 2025.
What is Can-Fite BioPharma's current ratio?
Can-Fite BioPharma had current assets of $9.4 million and current liabilities of $2.7 million, a current ratio of 3.46 (it can cover its short-term obligations).